These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19916908)
41. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues]. Chen L; Shen AG; Wang GL; Lu P; Li XY Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986 [TBL] [Abstract][Full Text] [Related]
42. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Fransvea E; Angelotti U; Antonaci S; Giannelli G Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443 [TBL] [Abstract][Full Text] [Related]
43. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
44. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
45. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism. Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513 [TBL] [Abstract][Full Text] [Related]
46. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
47. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells. Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861 [TBL] [Abstract][Full Text] [Related]
48. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report. Farid IM; Hamza IM; El-Abd DM; Mohyi AM; AbdulLatif MM; Aref AT; Hamza DM Arab J Gastroenterol; 2014; 15(3-4):142-7. PubMed ID: 25475758 [TBL] [Abstract][Full Text] [Related]
50. TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression. Huang J; Qiu M; Wan L; Wang G; Huang T; Chen Z; Jiang S; Li X; Xie L; Cai L Cell Physiol Biochem; 2018; 45(4):1690-1699. PubMed ID: 29490293 [TBL] [Abstract][Full Text] [Related]
51. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131 [TBL] [Abstract][Full Text] [Related]
52. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism. Tang JC; Liu JH; Liu XL; Liang X; Cai XJ World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967 [TBL] [Abstract][Full Text] [Related]
53. Dermatopontin augments angiogenesis and modulates the expression of transforming growth factor beta 1 and integrin alpha 3 beta 1 in endothelial cells. Krishnaswamy VR; Balaguru UM; Chatterjee S; Korrapati PS Eur J Cell Biol; 2017 May; 96(3):266-275. PubMed ID: 28336087 [TBL] [Abstract][Full Text] [Related]
54. [Correlation of triggering receptors expressed on myeloid cells-1 with the oncogenesis and progression of hepatocellular carcinoma]. Li W; Zhang N; Ou Y; Zhou Z; Zhao F; Wu Q; Yang Y Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1705-9, 1720. PubMed ID: 26714901 [TBL] [Abstract][Full Text] [Related]
55. [Gene expression of TGF-beta1 and its type II receptor in hepatocellular carcinoma]. Liu C; Chen S; Ou Q Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):740-2. PubMed ID: 11829941 [TBL] [Abstract][Full Text] [Related]
56. Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma. Pang M; Teng Y; Huang J; Yuan Y; Lin F; Xiong C Biochem Biophys Res Commun; 2017 Jan; 483(1):553-558. PubMed ID: 28025149 [TBL] [Abstract][Full Text] [Related]
57. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma. Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744 [TBL] [Abstract][Full Text] [Related]
58. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo. Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859 [TBL] [Abstract][Full Text] [Related]
60. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]